Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Young patients with non-germinal center B-cell-like diffuse large B-cell lymphoma benefit from intensified chemotherapy with ACVBP plus rituximab compared with CHOP plus rituximab: analysis of data from the Groupe d'Etudes des Lymphomes de l'Adulte/lymphoma study association phase III trial LNH 03-2B.
Molina TJ, Canioni D, Copie-Bergman C, Recher C, Brière J, Haioun C, Berger F, Fermé C, Copin MC, Casasnovas O, Thieblemont C, Petrella T, Leroy K, Salles G, Fabiani B, Morschauser F, Mounier N, Coiffier B, Jardin F, Gaulard P, Jais JP, Tilly H. Molina TJ, et al. Among authors: ferme c. J Clin Oncol. 2014 Dec 10;32(35):3996-4003. doi: 10.1200/JCO.2013.54.9493. Epub 2014 Nov 10. J Clin Oncol. 2014. PMID: 25385729 Clinical Trial.
Feasibility of tandem autologous stem-cell transplantation (ASCT) in induction failure or very unfavorable (UF) relapse from Hodgkin's disease (HD). SFGM/GELA Study Group.
Brice P, Divine M, Simon D, Coiffier B, Leblond V, Simon M, Voilat L, Devidas A, Morschhauser F, Rohrlich P, André M, Lepage E, Ferme C. Brice P, et al. Among authors: ferme c. Ann Oncol. 1999 Dec;10(12):1485-8. doi: 10.1023/a:1008343823292. Ann Oncol. 1999. PMID: 10643540 Free article. Clinical Trial.
Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the groupe d'études des lymphomes de l'Adulte H89 trial.
Fermé C, Sebban C, Hennequin C, Diviné M, Lederlin P, Gabarre J, Ferrant A, Caillot D, Bordessoule D, Brice P, Moullet I, Berger F, Lepage E. Fermé C, et al. Blood. 2000 Apr 1;95(7):2246-52. Blood. 2000. PMID: 10733492 Free article. Clinical Trial.
ALK is not expressed in Hodgkin disease.
Camilleri-Broët S, Audouin J, Fermé C, Brière J, Pulford K, Gaulard P, Diviné M, Macintyre E, Delsol G, Berger F. Camilleri-Broët S, et al. Among authors: ferme c. Blood. 2001 Mar 15;97(6):1901-2. doi: 10.1182/blood.v97.6.1901. Blood. 2001. PMID: 11263444 Free article. No abstract available.
Advanced Hodgkin disease with large mediastinal involvement can be treated with eight cycles of chemotherapy alone after a major response to six cycles of chemotherapy: a study of 82 patients from the Groupes d'Etudes des Lymphomes de l'Adulte H89 trial.
Brice P, Colin P, Berger F, de Kerviler E, Diviné M, Bouaffia F, Kerneis Y, Blanc M, Lepage E, Fermé C; Groupe d'Etude des Lymphomes de l'Adulte. Brice P, et al. Among authors: ferme c. Cancer. 2001 Aug 1;92(3):453-9. doi: 10.1002/1097-0142(20010801)92:3<453::aid-cncr1343>3.0.co;2-8. Cancer. 2001. PMID: 11505388 Clinical Trial.
Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial.
Fermé C, Mounier N, Diviné M, Brice P, Stamatoullas A, Reman O, Voillat L, Jaubert J, Lederlin P, Colin P, Berger F, Salles G. Fermé C, et al. J Clin Oncol. 2002 Jan 15;20(2):467-75. doi: 10.1200/JCO.2002.20.2.467. J Clin Oncol. 2002. PMID: 11786576 Clinical Trial.
135 results